These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 5684864)
41. Mediation of immunity to tumor-specific transplantation antigens by RNA inhibition of isograft growth in rats. Deckers PJ; Pilch YH Cancer Res; 1972 Apr; 32(4):839-46. PubMed ID: 5014793 [No Abstract] [Full Text] [Related]
42. Immunotherapy experiments with a methylcholanthrene-induced guinea pig liposarcoma. Eilber FR; Holmes EC; Morton DL J Natl Cancer Inst; 1971 Apr; 46(4):803-8. PubMed ID: 5573770 [No Abstract] [Full Text] [Related]
43. [An immunohistochemical study of the group specific antigen of mouse leukemia viruses]. Lezhneva OM; Abelev GI Vopr Virusol; 1971; 16(3):348-53. PubMed ID: 4332918 [No Abstract] [Full Text] [Related]
44. Strength of the tumour-specific antigens and of the "hybrid effect" of three chemically-induced sarcomas of the same inbred strain origin. Oth D; Burg C Folia Biol (Praha); 1970; 16(6):374-80. PubMed ID: 4394677 [No Abstract] [Full Text] [Related]
45. Ribonucleic acid-mediated inhibition and enhancement of tumor growth in mice. Ramming KP; Pilch YH Surg Forum; 1969; 20():106-9. PubMed ID: 5383020 [No Abstract] [Full Text] [Related]
46. Enhancing effect on tumour growth of humoral antibodies against tumour specific transplantation antigens in tumours induced by murine sarcoma virus(Harvey). Bubenik J; Turano A Nature; 1968 Nov; 220(5170):928-30. PubMed ID: 5722149 [No Abstract] [Full Text] [Related]
47. Measurement of the antitumoral immune reactions against a strain-specific chemically-induced sarcoma in syngeneic and F1 hybrid mice. Oth D; Donner M; Burg C Eur J Cancer (1965); 1971 Oct; 7(5):479-82. PubMed ID: 5159878 [No Abstract] [Full Text] [Related]
49. Brief communication: preliminary studies of tolerance to contact sensitization in carcinogen-fed guinea pigs. Pomeranz JR J Natl Cancer Inst; 1972 May; 48(5):1513-7. PubMed ID: 5030960 [No Abstract] [Full Text] [Related]
50. Tumor-specific immunity in 3-methylcholanthrene-induced murine fibrosarcomas. I. In vivo demonstration of immunity with three preparations of soluble antigens. Brannen GE; Adams JS; Santos GW J Natl Cancer Inst; 1974 Jul; 53(1):165-75. PubMed ID: 4600504 [No Abstract] [Full Text] [Related]
51. Immunosuppression and neoplasia. I. A critical review of experimental carcinogenesis and the immunesurveillance theory. Gleichmann H; Gleichmann E Klin Wochenschr; 1973 Mar; 51(6):255-9 contd. PubMed ID: 4147391 [No Abstract] [Full Text] [Related]
52. Effect of previous injection of homologous embryonic tissue on the growth of certain transplantable mouse tumours. Buttle GA; Frayn A Nature; 1967 Sep; 215(5109):1495-7. PubMed ID: 4862516 [No Abstract] [Full Text] [Related]
53. Inhibition of cell-mediated cytotoxicity to chemically induced rat tumours by soluble tumour and embryo cell extracts. Zöller M; Price MR; Baldwin RW Int J Cancer; 1976 Jan; 17(1):129-37. PubMed ID: 175021 [TBL] [Abstract][Full Text] [Related]
54. Immunogenic strength of sarcomas induced by methylcholanthrene in millipore filter diffusion chambers. Parmiani G; Carbone G; Lembo R Cancer Res; 1973 Apr; 33(4):750-4. PubMed ID: 4696474 [No Abstract] [Full Text] [Related]
55. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and incompatible tumor cells. Klein E; Klein G Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5056574 [No Abstract] [Full Text] [Related]
57. A preliminary investigation into the role of immunity in modifying the blood- borne spread of chemically induced rat sarcomas. Proctor JW; Rudenstam CM; Alexander P J Natl Cancer Inst; 1974 Dec; 53(6):1671-6. PubMed ID: 4373575 [No Abstract] [Full Text] [Related]
59. Incorporation of 125-I-iododeoxyuridine into target cells as an assay for cell immunity. Fish F; Yaakubovicz M; Witz IP J Natl Cancer Inst; 1974 Dec; 53(6):1743-7. PubMed ID: 4436870 [No Abstract] [Full Text] [Related]